ProVise Management Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

ProVise Management Group’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,900	Closed	-$202K	–	383
2022 Q1	$202K	Hold	4,900	–	–	0.02%	359
2021 Q4	$209K	Hold	4,900	–	–	0.02%	365
2021 Q3	$270K	Sell	4,900 -500	-9%	-$26.2K	0.03%	304
2021 Q2	$258K	Sell	5,400 -400	-7%	-$20.4K	0.03%	326
2021 Q1	$294K	Sell	5,800 -250	-4%	-$13.9K	0.03%	287
2020 Q4	$381K	Sell	6,050 -923	-13%	-$57.3K	0.04%	230
2020 Q3	$469K	Buy	6,973 +589	+9%	+$32.1K	0.06%	199
2020 Q2	$267K	Hold	6,384	–	–	0.04%	238
2020 Q1	$201K	Buy	6,384 +100	+2%	+$4K	0.03%	241
2019 Q4	$254K	Buy	+6,284	New	+$220K	0.03%	262

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ProVise Management Group's SILK Position: Q2 2022 in Review

ProVise Management Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2022, closing a stake of 4,900 shares — an estimated $202K sold.

ProVise Management Group first reported a position in SILK in Q4 2019 and held it in 10 quarters. The position peaked at $469K in Q3 2020. 139 funds tracked by Wall St. Rank hold SILK as of Q2 2022.

ProVise Management Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ProVise Management Group sold 4,900 Silk Road Medical, Inc. Common Stock shares in Q2 2022, an estimated $202K.
ProVise Management Group first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
ProVise Management Group's Silk Road Medical, Inc. Common Stock position peaked at $469K in Q3 2020.
139 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2022.

Based on ProVise Management Group's 13F filing for Q2 2022, filed 8 Aug 2022.